Healthcare organizations face a critical balancing act of maximizing AI’s transformative capabilities, while ensuring safety in patient care and measurable ROI. Faced with competitive pressure to quickly put AI solutions into practice, the stakes could not be higher, moving too quickly risks patient safety, and moving too slowly with its adoption risks falling behind.
In this session led by Dr. Ruben Amarasingham, CEO of Pieces Technologies, physician executive leaders from Children's Health, Houston Methodist Cypress, CHRISTUS Health and MetroHealth will share their tested recommendations for responsibly rolling out generative AI. They'll share practical insights on securing clinician buy-in, maintaining rigorous safety standards, and demonstrating clear ROI — offering a roadmap that other health systems can follow to accelerate AI adoption without compromising care quality.
Insights include:
- How health systems are approaching "human-in-the-loop" design to keep clinicians engaged
- What executives are doing to validate and demonstrate early ROI from generative AI
- Why AI governance and safety frameworks need to be top of mind—even facing mounting pressures to scale
%201.jpg?width=120&height=120&name=Desai_Nicholas%20Headshot%20(1)%201.jpg)
